Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098937 · ClinicalTrials.gov registry record · NA
Kalifilcon A Toric Compared to Commercially Available Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06098937 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants.
The verdict
NCT06098937, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.
Interventions
- DEVICE Precision1 for Astigmatism
- DEVICE Kalifilcon Toric Lens
- DEVICE Total1 for Astigmatism
- DEVICE MyDay Toric
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2023-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06098937
The ClinicalTrials.gov registry entry for NCT06098937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Precision1 for Astigmatism is the first listed.
NCT06098937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06098937 about?
NCT06098937 is a clinical study titled "Kalifilcon A Toric Compared to Commercially Available Lenses". Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.
What is the current status of trial NCT06098937?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-09-05. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT06098937?
The interventions under investigation include: Precision1 for Astigmatism (DEVICE), Kalifilcon Toric Lens (DEVICE), Total1 for Astigmatism (DEVICE), MyDay Toric (DEVICE).
Who is sponsoring clinical trial NCT06098937?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.